Exosome engineering for efficient and targeted drug delivery: current status and future perspective

Farzaneh Malekian,Alireza Shamsian,Sai Priyanka Kodam,Mujib Ullah
DOI: https://doi.org/10.1113/JP282799
2022-05-17
Journal of Physiology
Abstract:Exosomes are membrane‐bound vesicles that are released by most cells. They carry nucleic acids, cytokines, growth factors, proteins, lipids, and metabolites. They are responsible for inter‐ and intra‐cellular communications and their role in drug delivery is well defined. Exosomes have great potential for therapeutic applications, but the clinical use is restricted due to limitations in standardized procedures for isolation, purification, and drug delivery. Bioengineering of exosomes could be one approach to achieve standardization and reproducible isolation for clinical use. Exosomes are important transporters for targeted drug delivery because of their small size, stable structure, non‐immunogenic, non‐toxic nature, and the ability to carry a wide variety of compounds. These features of exosomes can be enhanced further by bioengineering. In this review, possible exosome bioengineering approaches, their biomedical applications, and targeted drug delivery are being discussed. figure legend Exosomes Bioengineering for efficient and targeted drug delivery. Reprogrammed exosomes release the cargo of growth and regenerative factors more effectively than naïve exosomes for tissue engineering and can be used as a drug delivery platform. This article is protected by copyright. All rights reserved
What problem does this paper attempt to address?